Machina Capital S.A.S. Eli Lilly & CO Transaction History

Machina Capital S.A.S.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $735,266 - $866,782	1,400 New	1,400 $816,000
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $225,085 - $262,269	700 New	700 $256,000
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $390,222 - $458,178	-1,400 Closed	0 $0
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $328,566 - $408,324	1,400 New	1,400 $401,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $345,779 - $428,278	-3,234 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $1.46 Million - $1.59 Million	-13,704 Reduced 80.91%	3,234 $362,000
Q2 2019 Jul 19, 2019	BUY	$110.79 - $129.32 $1.19 Million - $1.38 Million	10,709 Added 171.92%	16,938 $1.88 Million
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $693,349 - $816,123	6,229 New	6,229 $808,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.